tranScrip
Rachael Cavanagh is an experienced professional in regulatory affairs, currently serving as Senior Manager Regulatory Affairs at tranScrip since April 2023. Prior roles include Regulatory Lead at Cmed Clinical Services from January 2022 to April 2023 and various positions at Parexel from February 2016 to December 2021, encompassing roles such as Regulatory Affairs Consultant and Senior Project Manager. Rachael's earlier experience includes serving as a Senior Regulatory Affairs Executive at Wockhardt UK from July 2011 to February 2016, overseeing regulatory staff and operations for both Wockhardt UK and its sister company in Ireland. Rachael began their career as a Clinical Research Manager at Research Education in Dentistry in 2010. Rachael holds a BSc Honours degree in Pharmaceutical Sciences Clinical Research from Liverpool John Moores University, graduated in 2010.
This person is not in any offices
tranScrip
tranScrip is a leading contract drug development organisation which supports pharma and biotech companies in the development and lifecycle of medicines. We bring innovative solutions to clients’ global drug development needs. From translational medicine through to registration and post licencing, we deliver both strategic leadership and operational execution of development programmes, covering clinical, regulatory, drug safety, and commercial elements. Our teams of physicians, scientists and regulatory experts, help clients select the most promising drug candidates and bring them to the market. We guide our clients through their decision making from first in man studies to proof of concept and pivotal trials, regulatory submissions and product launches. In the last decade, tranScrip has supported over 250 clients and has been integral to many development programmes and regulatory submissions, bringing products to the market each year across a wide range of therapeutic areas.